Kodiak Sciences Inc. — Investor Relations & Filings
Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company focused on researching, developing, and commercializing therapeutics for chronic, high-prevalence retinal diseases. The company's mission is to address the leading causes of blindness, such as wet age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. Its core technology is the proprietary Antibody Biopolymer Conjugate Drug (ABCD) Platform, which is designed to create long-acting biologics with enhanced durability, potentially reducing treatment frequency for patients. Kodiak's late-stage clinical pipeline includes its lead candidate, tarcocimab tedromer, an anti-VEGF therapy, as well as other candidates targeting retinal vascular diseases and macular edema.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Kodiak Sciences Inc. (0001468748) (Filer) | 2026-05-07 | English | |
| 10-K - Kodiak Sciences Inc. (0001468748) (Filer) | 2026-03-31 | English | |
| 4 - Kodiak Sciences Inc. (0001468748) (Issuer) | 2026-03-27 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 5 Filing | 2026-02-17 | English | |
| Major Shareholding Notification 2025 | 2025-12-19 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 43476817 | 8-K - Kodiak Sciences Inc. (0001468748) (Filer) | 2026-05-07 | English | ||
| 33122720 | 10-K - Kodiak Sciences Inc. (0001468748) (Filer) | 2026-03-31 | English | ||
| 33066636 | 4 - Kodiak Sciences Inc. (0001468748) (Issuer) | 2026-03-27 | English | ||
| 29966374 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29966373 | 5 Filing | 2026-02-17 | English | ||
|
2025
10 filings
| |||||
| 12296065 | Major Shareholding Notification 2025 | 2025-12-19 | English | ||
| 12296064 | 4 | 2025-12-19 | English | ||
| 12296068 | 8-K | 2025-12-18 | English | ||
| 12296067 | 424B5 | 2025-12-17 | English | ||
| 12296069 | 424B5 | 2025-12-15 | English | ||
| 12296066 | 10-Q | 2025-11-13 | English | ||
| 12296070 | 8-K | 2025-11-13 | English | ||
| 12296071 | Major Shareholding Notification 2025 | 2025-08-19 | English | ||
| 12296072 | 10-Q | 2025-08-13 | English | ||
| 12296073 | 8-K | 2025-08-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Coeptis Therapeutics Holdings, Inc.
Biopharmaceutical company developing cell therapy platforms…
|
COEP | US | Manufacturing |
|
Cogent Biosciences, Inc.
A clinical-stage biotech company developing precision thera…
|
COGT | US | Manufacturing |
|
Cohance Lifesciences Limited
Global CDMO and API platform offering end-to-end solutions …
|
COHANCE | IN | Manufacturing |
|
Coherus Oncology, Inc.
Biopharmaceutical company developing and commercializing im…
|
CHRS | US | Manufacturing |
|
Colinz Laboratories ltd.
Manufactures and markets medicinal formulations across dive…
|
531210 | IN | Manufacturing |
|
COLLEGIUM PHARMACEUTICAL, INC
A biopharmaceutical company developing abuse-deterrent pain…
|
COLL | US | Manufacturing |
|
CollPlant Biotechnologies Ltd
Develops plant-derived collagen for 3D bioprinting of tissu…
|
CLGN | US | Manufacturing |
|
COMPASS Pathways plc
Develops psilocybin treatments for difficult-to-treat menta…
|
CMPS | GB | Manufacturing |
|
Compass Therapeutics, Inc.
Clinical-stage biopharma developing antibody-based therapeu…
|
CMPX | US | Manufacturing |
|
Concord Biotech Limited
R&D-driven producer of fermentation-based APIs and formulat…
|
CONCORDBIO | IN | Manufacturing |
Kodiak Sciences Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32371/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32371 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32371 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32371 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32371}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Kodiak Sciences Inc. (id: 32371)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.